Daiwa Securities Group Inc. Sells 4,402 Shares of Globe Life Inc. $GL

Daiwa Securities Group Inc. decreased its holdings in shares of Globe Life Inc. (NYSE:GL) by 7.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 58,761 shares of the company’s stock after selling 4,402 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Globe Life were worth $8,219,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the company. CIBC Asset Management Inc lifted its position in shares of Globe Life by 65.7% in the 4th quarter. CIBC Asset Management Inc now owns 18,126 shares of the company’s stock worth $2,535,000 after acquiring an additional 7,186 shares during the period. Marble Wealth LLC bought a new stake in shares of Globe Life in the 4th quarter worth approximately $1,038,000. Natixis Advisors LLC lifted its position in shares of Globe Life by 2.1% in the 4th quarter. Natixis Advisors LLC now owns 22,625 shares of the company’s stock worth $3,164,000 after acquiring an additional 455 shares during the period. MUFG Securities EMEA plc lifted its position in shares of Globe Life by 110.5% in the 4th quarter. MUFG Securities EMEA plc now owns 3,263 shares of the company’s stock worth $456,000 after acquiring an additional 1,713 shares during the period. Finally, BNP Paribas Financial Markets lifted its position in shares of Globe Life by 14.2% in the 4th quarter. BNP Paribas Financial Markets now owns 170,331 shares of the company’s stock worth $23,822,000 after acquiring an additional 21,115 shares during the period. Institutional investors own 81.61% of the company’s stock.

Analysts Set New Price Targets

GL has been the subject of a number of research reports. Keefe, Bruyette & Woods reiterated a “moderate buy” rating and issued a $168.00 price objective on shares of Globe Life in a research report on Thursday, March 26th. Truist Financial raised their price objective on Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a research report on Friday, April 24th. Weiss Ratings raised Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, May 13th. Texas Capital raised Globe Life to a “strong-buy” rating in a report on Wednesday, March 18th. Finally, Morgan Stanley increased their target price on Globe Life from $176.00 to $181.00 and gave the stock an “overweight” rating in a report on Thursday, May 21st. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $174.11.

Globe Life Trading Up 0.1%

GL stock opened at $159.28 on Monday. The business has a fifty day moving average price of $150.46 and a 200 day moving average price of $143.52. Globe Life Inc. has a fifty-two week low of $116.73 and a fifty-two week high of $159.36. The stock has a market capitalization of $12.37 billion, a price-to-earnings ratio of 11.02 and a beta of 0.49. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The business had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the prior year, the business earned $3.07 earnings per share. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Analysts expect that Globe Life Inc. will post 15.62 EPS for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is currently 9.13%.

Insiders Place Their Bets

In other Globe Life news, CEO Frank M. Svoboda sold 20,000 shares of the stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $156.68, for a total value of $3,133,600.00. Following the transaction, the chief executive officer directly owned 54,020 shares in the company, valued at approximately $8,463,853.60. This trade represents a 27.02% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO James Matthew Darden sold 4,663 shares of the stock in a transaction on Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total value of $717,542.44. Following the completion of the transaction, the chief executive officer owned 58,451 shares in the company, valued at $8,994,439.88. The trade was a 7.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 105,929 shares of company stock valued at $16,382,450. Company insiders own 2.11% of the company’s stock.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.